Long chain fatty acid uptake in vivo:: Comparison of [125I]-BMIPP and [3H]-bromopalmitate

被引:11
|
作者
Shearer, Jane [1 ,2 ,3 ]
Coenen, Kimberly R. [3 ]
Pencek, R. Richard [3 ]
Swift, Larry L. [4 ]
Wasserman, David H. [3 ,6 ]
Rottman, Jeffrey N. [5 ,6 ]
机构
[1] Univ Calgary, Dept Kinesiol, Calgary, AB T2N 1N4, Canada
[2] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada
[3] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA
[5] Vanderbilt Univ, Dept Cardiol, Nashville, TN 37232 USA
[6] Vanderbilt Univ, Mouse Metab Phenotyping Ctr, Nashville, TN 37232 USA
关键词
tracer; kinetics; thin layer chromatography; uptake; clearance;
D O I
10.1007/s11745-008-3183-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Insulin resistance is characterized by increased metabolic uptake of fatty acids. Accordingly, techniques to examine in vivo shifts in fatty acid metabolism are of value in both clinical and experimental settings. Partially metabolizable long chain fatty acid (LCFA) tracers have been recently developed and employed for this purpose: [9,10-H-3]-(R)-2-bromopalmitate ([H-3]-BROMO) and [I-125]-15-(rho-iodophenyl)-3-R,S-methylpentadecanoic acid ([I-125]-BMIPP). These analogues are taken up like native fatty acids, but once inside the cell do not directly enter beta-oxidation. Rather, they become trapped in the slower processes of omega and alpha-oxidation. Study aims were to (1) simultaneously assess and compare [H-3]-BROMO and [I-125]-BMIPP and (2) determine if tracer breakdown is affected by elevated metabolic demands. Catheters were implanted in a carotid artery and jugular vein of Sprague-Dawley rats. Following 5 days recovery, fasted animals (5 h) underwent a rest (n = 8) or exercise (n = 8) (0.6 mi/h) protocol. An instantaneous bolus containing both [H-3]-BROMO and [I-125]-BMIPP was administered to determine LCFA uptake. No significant difference between [I-125]-BMIPP and [H-3]-BROMO uptake was found in cardiac or skeletal muscle during rest or exercise. In liver, rates of uptake were more than doubled with [H-3]-BROMO compared to [I-125]-BMIPP. Analysis of tracer conversion by TLC demonstrated no difference at rest. Exercise resulted in greater metabolism and excretion of tracers with similar to 37% and similar to 53% of [I-125]-BMIPP and [H-3]-BROMO present in conversion products at 40 min. In conclusion, [H-3]-BROMO and [I-125]-BMIPP are indistinguishable for the determination of tissue kinetics at rest in skeletal and cardiac muscle. Exercise preferentially exacerbates the breakdown of [H-3]-BROMO, making [I-125]-BMIPP the analogue of choice for prolonged (> 30 min) experimental protocols with elevated metabolic demands.
引用
收藏
页码:703 / 711
页数:9
相关论文
共 50 条
  • [21] COMPARATIVE-STUDY OF A DOUBLE EXTRACTION 3H HYDROXY VITAMIN-D PROCEDURE WITH A DIRECT MODIFIED 125I METHOD
    MUNOZ, L
    REED, J
    WECKSLER, W
    CLINICAL CHEMISTRY, 1995, 41 (06) : S41 - S41
  • [22] Microscopic doses absorbed by cell nucleus from beta-rays of 3H and 14C, and compared with that of 125I
    Unak, T
    Unak, P
    INTERNATIONAL CONFERENCE ON NUCLEAR DATA FOR SCIENCE AND TECHNOLOGY, VOL 59, PT 1 AND 2, 1997, 59 : 1277 - 1279
  • [23] Comparison of the binding of [3H]NC(1-13)NH2, [3H]NCOH and [125I]Y14NCOH to recombinant human nociceptin receptors expressed in Chinese hamster ovary cells.
    Hashiba, E
    Lambert, DG
    Toth, G
    Smith, G
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 : U117 - U117
  • [24] [3H]anandamide metabolism by Tetrahymena pyriformis, in vivo and in vitro.: Partial characterization of a fatty acid amidohydrolase
    Karava, V
    Zafiriou, MP
    Fasia, L
    Siafaka-Kapadai, A
    CHEMISTRY AND PHYSICS OF LIPIDS, 2004, 130 (01) : 33 - 34
  • [25] Characterization of Sigma-2 Receptor-Specific Binding Sites Using [3H]DTG and [125I]RHM-4
    Weng, Chi-Chang
    Riad, Aladdin
    Lieberman, Brian P.
    Xu, Kuiying
    Peng, Xin
    Mikitsh, John L.
    Mach, Robert H.
    PHARMACEUTICALS, 2022, 15 (12)
  • [26] In vivo characterization of a metabolically trapped long chain fatty acid - Iodo-PHIPA 3-10.
    Brandau, W
    Jonas, M
    Puskas, C
    Vollet, B
    Gildehaus, FJ
    Weyand, M
    Fahrenkamp, A
    Schober, O
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 186 - 186
  • [27] Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates
    Luiken, Joost J. F. P.
    Niessen, Hanneke E. C.
    Coort, Susan L. M.
    Hoebers, Nicole
    Coumans, Will A.
    Schwenk, Robert W.
    Bonen, Arend
    Glatz, Jan F. C.
    BIOCHEMICAL JOURNAL, 2009, 419 : 447 - 455
  • [28] MYOCARDIAL UPTAKE AND INVIVO DISTRIBUTION OF I-123 LABELED LONG-CHAIN FATTY-ACID DERIVATIVES IN RATS
    LIN, TH
    HARRIS, GE
    BALDWIN, RM
    WU, JL
    LAMB, JF
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1982, 19 (11-1): : 1314 - 1315
  • [29] Radiolabeled prodrug (125I) ammonium 2-(2′-phosphorloxyphenyl)-6-iodo-4-(3H)-quinazolinone:: Synthesis and biological evaluation.
    Ho, NH
    Harapanhalli, R
    Dahman, B
    Adelstein, J
    Kassis, AI
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U54 - U54
  • [30] In Vivo Optical Metabolic Imaging of Long-Chain Fatty Acid Uptake in Orthotopic Models of Triple-Negative Breast Cancer
    Madonna, Megan C.
    Duer, Joy E.
    Lee, Joyce V.
    Williams, Jeremy
    Avsaroglu, Baris
    Zhu, Caigang
    Deutsch, Riley
    Wang, Roujia
    Crouch, Brian T.
    Hirschey, Matthew D.
    Goga, Andrei
    Ramanujam, Nirmala
    CANCERS, 2021, 13 (01) : 1 - 20